Assignee
AMORSA THERAPEUTICS INC
US7 patents
Top patents by PatentIndex Score
US10252982B2Apr 9, 2019
Neuro-attenuating ketamine and norketamine compounds, derivatives thereof, and methods
AMORSA THERAPEUTICS INC14 citations93
US9913803B2Mar 13, 2018
Single-layer oral dose of neuro-attenuating ketamine
AMORSA THERAPEUTICS INC12 citations92
US10653629B2May 19, 2020
Single layer oral dose of neuro-attenuating ketamine
AMORSA THERAPEUTICS INC6 citations83
US11613515B2Mar 28, 2023
Neuro-attenuating ketamine and norketamine compounds, derivatives thereof, and methods
AMORSA THERAPEUTICS INC2 citations72
US11603348B2Mar 14, 2023
Neuro-attenuating ketamine and norketamine compounds, derivatives thereof, and methods
AMORSA THERAPEUTICS INC1 citations72
US11554100B2Jan 17, 2023
Single-layer oral dose of neuro-attenuating ketamine
AMORSA THERAPEUTICS INC2 citations72
US10981859B2Apr 20, 2021
Neuro-attenuating ketamine and norketamine compounds, derivatives thereof, and methods
AMORSA THERAPEUTICS INC1 citations72